Research

Hormonal

There are confirmed cases of falsified GLP-1 receptor agonists in Brazil, indicating supply chain vulnerabilities.

Counterfeit GLP-1 drugs have been confirmed in Brazil. Patients should obtain medications through regulated channels to avoid falsified products.

GoodSupportsHIGH confidence
Between January 2024 and September 2025, eight confirmed episodes of falsification were identified, involving seven cases of semaglutide and one case of liraglutide.
Renato Lopes Hurtado et al. · Diabetes Obesity and Metabolism · 2026

Why this rating

Confirmed regulatory alerts, though likely underestimates true volume.

Source

<scp>GLP</scp> ‐1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation

Renato Lopes Hurtado et al. · Diabetes Obesity and Metabolism · 2026

DOI 10.1111/dom.70609

cross_sectional
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →